Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 6 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 6 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 9 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

We like comments, but …

Like other bloggers, we really like comments. But also like many other bloggers, we review all comments before publishing them. Here are a few guidelines to help get your comments published on this blog.

  • Keep them short. We keep most of our blog posts to a few sentences, so we like comments to do the same.
  • Keep them relevant. If your comment does not refer even indirectly to the blog post on which the comment is made, don’t expect it to be published.
  • Keep them civil. All of our blog posts are respectful and businesslike. Take your profanity and bad manners elsewhere.

Comments are closed.